Log In
Copyright © 2009 American Chemical Society
December 7, 2009 Cover
Volume 87, Issue 49
COVER: A Roche scientist assists in the production of Avastin, a biotherapeutic approved for the treatment of some cancers, at the company’s biotech facility in Basel, Switzerland.
Volume 87, Issue 49
PHARMA REFORMULATES
Drug firms implement new business strategies to deflect mounting market pressures and accelerate into new geographies
COVER: A Roche scientist assists in the production of Avastin, a biotherapeutic approved for the treatment of some cancers, at the company’s biotech facility in Basel, Switzerland.
Credit: Roche
» Full Article
December 7, 2009 Issue
Volume 87, Issue 49
December 7, 2009 Issue, Vol. 87 | Iss. 49
Drug firms implement new business strategies to deflect mounting market pressures and accelerate into new geographies
(pp. 13-21)
Features
Government & Policy
Chemical industry pins hopes on senate in fight over facility security (pp. 34-37)
Science & Technology
Meeting highlights how friction triggers molecular-scale changes in adhesive tape, cosmetics, and more (pp. 47-49)
News of the Week
On To Copenhagen
Climate Change: World leaders to hammer out global response to limit greenhouse gases
(p.7)ACC Bulks Up
Membership Drive: Trade group seeks smaller members as chemical industry's fortunes improve
(p.8)Screen Nets Self-Destruction Stoppers
Chemical Biology: Strategy finds selective ligands for rogue T cells
(p.8)HIV Drugs
Indian manufacturers will adjust to new WHO guidelines
(p.9)Metalloprotein Made To Order
Bioinorganic Chemistry: Researchers construct metalloenzyme active site in another protein
(p.9)Customized Nanoparticles
Catalysis: Method endows platinum
with benefits of solid- and solution-phase catalysts
(p.10)Momentum For Chemical Control
TSCA: Senate panel examines toxic substances act, 13 states call for reform
(p.10)Departments
Business
After a painful year, company says it has the portfolio it needs for unprecedented expansion of its business
(pp. 25-26)
Scavenging shuttered chemical plants can be profitable, but not in this economy
(pp. 28-29)
Within months, the contract research firm entered a manufacturing joint venture and bought a plant
(pp. 30-31)
Drug firms implement new business strategies to deflect mounting market pressures and accelerate into new geographies
(pp. 13-21)Concentrates
(pp. 22-23)
(pp. 22-23)- Big Firms Invest In Europe
- New Head For SOCMA
- Europe’s Competition Agency
- Tetra Pak Will Buy Green Polyethylene
- SABIC, Linde Launch α‑olefins Technology
- Air Liquide Acquires Hydrogen Technology
- Covance Invests In Food Testing
- Micromet Signs Deals With Bayer And Lonza
- Pfizer Inks Gaucher’s Deal With Protalix
- Sasol Will Double Synthetic Wax
- PPG And Lignol Cooperate On Lignin
- Process R&D Institute Opens New Laboratory
- AstraZeneca Licenses Depression Therapy
- Business Roundup
Government & Policy
Chemical industry pins hopes on senate in fight over facility security
(pp. 34-37)
State Department taps three prominent scientists to reach out to muslim communities
(pp. 38-39)
Science & Technology
State Department program raises awareness about lab safety and security in developing countries
(pp. 44-46)
Meeting highlights how friction triggers molecular-scale changes in adhesive tape, cosmetics, and more
(pp. 47-49)Career & Employment
Recent uptick in biology hiring could herald jobs for chemists in drug discovery
(pp. 53-56)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings